Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1957 1
1959 1
1963 2
1964 5
1966 1
1967 2
1968 2
1969 3
1970 6
1971 6
1972 5
1973 5
1974 8
1975 5
1976 5
1977 5
1978 5
1979 6
1980 10
1981 9
1982 2
1983 16
1984 5
1985 11
1986 5
1987 9
1988 6
1989 9
1990 11
1991 10
1992 12
1993 14
1994 13
1995 11
1996 18
1997 10
1998 23
1999 17
2000 33
2001 16
2002 12
2003 17
2004 17
2005 14
2006 19
2007 23
2008 23
2009 17
2010 33
2011 29
2012 24
2013 22
2014 24
2015 29
2016 22
2017 25
2018 38
2019 36
2020 41
2021 40
2022 38
2023 46
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

852 results

Results by year

Filters applied: . Clear all
Page 1
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, Bryce A, Chapin B, Cheng HH, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Guzzo T, Ippolito JE, Kuettel MR, Lang JM, Lotan T, McKay RR, Morgan T, Netto G, Pow-Sang JM, Reiter R, Roach M, Robin T, Rosenfeld S, Shabsigh A, Spratt D, Teply BA, Tward J, Valicenti R, Wong JK, Berardi RA, Shead DA, Freedman-Cass DA. Schaeffer EM, et al. Among authors: roach m. J Natl Compr Canc Netw. 2022 Dec;20(12):1288-1298. doi: 10.6004/jnccn.2022.0063. J Natl Compr Canc Netw. 2022. PMID: 36509074
High-risk prostate cancer-classification and therapy.
Chang AJ, Autio KA, Roach M 3rd, Scher HI. Chang AJ, et al. Among authors: roach m 3rd. Nat Rev Clin Oncol. 2014 Jun;11(6):308-23. doi: 10.1038/nrclinonc.2014.68. Epub 2014 May 20. Nat Rev Clin Oncol. 2014. PMID: 24840073 Free PMC article. Review.
Editorial Comment.
Sabol RA, Roach M 3rd. Sabol RA, et al. Among authors: roach m 3rd. J Urol. 2022 Dec;208(6):1238-1239. doi: 10.1097/JU.0000000000002902.03. Epub 2022 Dec 1. J Urol. 2022. PMID: 36349917 No abstract available.
Radiotherapy of oligometastatic prostate cancer: a systematic review.
Rogowski P, Roach M 3rd, Schmidt-Hegemann NS, Trapp C, von Bestenbostel R, Shi R, Buchner A, Stief C, Belka C, Li M. Rogowski P, et al. Among authors: roach m 3rd. Radiat Oncol. 2021 Mar 9;16(1):50. doi: 10.1186/s13014-021-01776-8. Radiat Oncol. 2021. PMID: 33750437 Free PMC article.
Editorial Comment.
Chen WS, Roach M. Chen WS, et al. Among authors: roach m. J Urol. 2022 Jun;207(6):1234-1235. doi: 10.1097/JU.0000000000002455.01. Epub 2022 Mar 14. J Urol. 2022. PMID: 35282698 No abstract available.
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA. Mohler JL, et al. Among authors: roach m. J Natl Compr Canc Netw. 2019 May 1;17(5):479-505. doi: 10.6004/jnccn.2019.0023. J Natl Compr Canc Netw. 2019. PMID: 31085757
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
Esteva A, Feng J, van der Wal D, Huang SC, Simko JP, DeVries S, Chen E, Schaeffer EM, Morgan TM, Sun Y, Ghorbani A, Naik N, Nathawani D, Socher R, Michalski JM, Roach M 3rd, Pisansky TM, Monson JM, Naz F, Wallace J, Ferguson MJ, Bahary JP, Zou J, Lungren M, Yeung S, Ross AE; NRG Prostate Cancer AI Consortium; Sandler HM, Tran PT, Spratt DE, Pugh S, Feng FY, Mohamad O. Esteva A, et al. Among authors: roach m 3rd. NPJ Digit Med. 2022 Jun 8;5(1):71. doi: 10.1038/s41746-022-00613-w. NPJ Digit Med. 2022. PMID: 35676445 Free PMC article.
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
Michalski JM, Winter KA, Prestidge BR, Sanda MG, Amin M, Bice WS, Gay HA, Ibbott GS, Crook JM, Catton CN, Raben A, Bosch W, Beyer DC, Frank SJ, Papagikos MA, Rosenthal SA, Barthold HJ, Roach M 3rd, Moughan J, Sandler HM. Michalski JM, et al. Among authors: roach m 3rd. J Clin Oncol. 2023 Aug 20;41(24):4035-4044. doi: 10.1200/JCO.22.01856. Epub 2023 Jun 14. J Clin Oncol. 2023. PMID: 37315297 Clinical Trial.
Thoracoscopic diaphragm plication.
Kara HV, Roach MJ, Balderson SS, D'Amico TA. Kara HV, et al. Among authors: roach mj. Ann Cardiothorac Surg. 2015 Nov;4(6):573-5. doi: 10.3978/j.issn.2225-319X.2015.08.11. Ann Cardiothorac Surg. 2015. PMID: 26693159 Free PMC article. Review. No abstract available.
Race, Biology, Disparities, and Prostate Cancer.
Vickers AJ, Elfiky A, Freeman VL, Roach M 3rd. Vickers AJ, et al. Among authors: roach m 3rd. Eur Urol. 2022 May;81(5):463-465. doi: 10.1016/j.eururo.2022.02.007. Epub 2022 Feb 22. Eur Urol. 2022. PMID: 35216858 No abstract available.
852 results